Results 201 to 210 of about 1,261,489 (334)

Tissue Engineering and Dental Implantology: Biomaterials, New Technologies, and Stem Cells [PDF]

, 2016
Gilberto Sammartino, David M. Dohan Ehrenfest, Jamil Awad Shibli, Pablo Galindo‐Moreno   +3 more
openalex   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Editorial: Advances in biotechnological approaches for reproductive tissue engineering. [PDF]

Front Bioeng Biotechnol
Almeida GHDR, Bressan FF, Miglino MA, Kim MS, Carreira ACO.   +4 more
europepmc   +1 more source

Recent advances in laser-based nano-engineering of tissue scaffolds

Hin Kei Kim, Seung Hoon Woo
openalex   +2 more sources

Einfluss von Extrazellulärmatrix-Molekülen auf das Tissue Engineering von Knorpelgewebe

, 2010
Christian Andreas Georg Egger
openalex   +1 more source

Supplementary Material for: Complex Material Properties of Gel-Amin: A Transparent and Ionically Conductive Hydrogel for Neural Tissue Engineering

, 2022
Neuman K.E., Alex Kenny, Lei Shi, Koppes A.N., Koppes R.A.   +4 more
openalex   +1 more source

Redox regulation meets metabolism: targeting PRDX2 to prevent hepatocellular carcinoma

Molecular Oncology, EarlyView.
PRDX2 acts as a central redox hub linking metabolic dysfunction‐associated steatohepatitis (MASH) to hepatocellular carcinoma (HCC). In normal hepatocytes, PRDX2 maintains redox balance and metabolic homeostasis under oxidative stress. In contrast, during malignant transformation, PRDX2 promotes oncogenic signaling, stemness, and tumor initiation ...
Naroa Goikoetxea‐Usandizaga, María Luz Martinez‐Chantar, Carolina Conter   +2 more
wiley   +1 more source

Organ-on-a-Chip and Lab-on-a-Chip Technologies in Cardiac Tissue Engineering. [PDF]

Biomimetics (Basel)
Marazzi D, Trovalusci F, Di Nardo P, Carotenuto F.   +3 more
europepmc   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Decellularized rat tubules for tissue engineering. [PDF]

Transl Androl Urol
Jia Q, Li K, Liu T, Kong F, Zhao S, Yang X, Guan Y.   +6 more
europepmc   +1 more source